On August 26, 2019 Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, reported that Charles Wilson, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in September (Press release, Unum Therapeutics, AUG 26, 2019, View Source [SID1234538998]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 17th Annual Global Healthcare Conference. Fireside chat on Monday, September 9, 2019 at 11:40 a.m. ET in New York City.

H.C. Wainwright 21st Annual Healthcare Conference. Presentation on Tuesday, September 10, 2019 at 10:25 a.m. ET in New York City.

The presentations will be webcast live, available for replay on the "Events" section of Unum’s investor relations webpage (investors.unumrx.com/events), and archived for approximately 90 days.